KLAR — Klaria Pharma Holding AB (publ) Share News
0.000.00%
- SEK123.23m
- SEK124.47m
- SEK8.99m
Brief: Klaria Pharma Holding Q3 Loss After Tax Widens To SEK 13.3 Mln
Brief: Klaria Pharma Receives SEK 24.5 Mln Through Directed New Issue
Brief: Klaria Pharma Gets Approval For Study With Sumatriptan Alginatfilm
Brief: Klaria's CEO And Chairman Buys Shares In Klaria
Brief: Klaria Pharma Regains Rights To Epinephrine Alginate Film From Purdue Canada and Mundipharma Network
Brief: Klaria Pharma Q2 Loss After Tax Widens To SEK 10.1 Mln
Brief: Klaria Pharma Holding Partners With Chilam Enterprise To Power Expansion To Medical Cannabis Sector
Brief: Klaria Pharma Holding Decides On Directed Issue Of Up To 3.8 Million Shares
Brief: Klaria Pharma Holding Launches Clinical Program For Naloxone Alginatefilm Against Opioid Overdose
Brief: Klaria Pharma Q1 Net Loss Widens To SEK 11.0 Mln
Brief: Klaria Pharma's CEO Increases His Holdings In Co
Brief: Klaria Pharma: Registration Office Grants Authorization For Merger Plan With Karessa Pharma
Brief: Klaria Pharma Q4 Loss After Tax Narrows To SEK 5.3 Mln
Brief: Klaria Pharma Holding Receives Payment Of Sek 6.4 Mln
Brief: Klaria Receives SEK 6.4 Mln Milestone Payment From EU's Horizon 2020 Program
Brief: Klaria Pharma Presents New Strategy
Brief: Karessa Pharma Holding Merger With Klaria Expected Completed March 6th
Brief: Klaria Pharma Appoints Jesper Wiklund As CEO
Brief: Klaria Pharma Q3 Loss Widens To SEK 7.2 Mln